Literature DB >> 31719731

Are thalassemia patients oxidatively challenged?

Mithu Banerjee1, Ashwini Kumar2, H S Batra3, S Bandyopadhyay4, Rajan Kapoor5.   

Abstract

BACKGROUND: Repeated blood transfusions is the mainstay of treatment for beta thalassemia major patients. Multiple blood transfusions lead to significant iron overload in these patients. Iron overload causes liberation of oxygen free radicals and peroxidative lipid injury. This study has been designed to study whether thalassemics suffer from oxidative injury. It also aims to study the quantum of oxidative injury.
METHODS: It is a cross sectional study using cases and controls. Thirty thalassemic patients receiving multiple blood transfusions were included in this study and thirty healthy age and sex matched controls were recruited for the study. Serum ferritin levels, malondialdehyde, nitric oxide levels were estimated.
RESULTS: Levels of all the three parameters were significantly increased (p < 0.05) in the cases compared to controls. Mean levels of all three parameters were correlated with serum ferritin levels and number of blood transfusions in increasing order. All the parameters showed fair degree of correlation (r ≥ 0.25, p ≤ 0.05).
CONCLUSION: Thalassemic patients receiving multiple blood transfusion suffer from iron overload which results in increased oxidative stress.
© 2018 Published by Elsevier B.V. on behalf of Director General, Armed Forces Medical Services.

Entities:  

Keywords:  Ferritin; Malondialdehyde; Nitric oxide; Oxidative stress; Thalassemia major

Year:  2018        PMID: 31719731      PMCID: PMC6838476          DOI: 10.1016/j.mjafi.2017.12.002

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  16 in total

1.  Hepatic iron concentration and total body iron stores in thalassemia major.

Authors:  E Angelucci; G M Brittenham; C E McLaren; M Ripalti; D Baronciani; C Giardini; M Galimberti; P Polchi; G Lucarelli
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

2.  Transfusion-dependent thalassaemia: a new era.

Authors:  Vasili Berdoukas; Bernadette Modell
Journal:  Med J Aust       Date:  2008-01-21       Impact factor: 7.738

Review 3.  Iron metabolism, free radicals, and oxidative injury.

Authors:  J Emerit; C Beaumont; F Trivin
Journal:  Biomed Pharmacother       Date:  2001-07       Impact factor: 6.529

4.  Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors.

Authors:  F Nielsen; B B Mikkelsen; J B Nielsen; H R Andersen; P Grandjean
Journal:  Clin Chem       Date:  1997-07       Impact factor: 8.327

5.  Urinary hepcidin in congenital chronic anemias.

Authors:  Susan L Kearney; Elizabeta Nemeth; Ellis J Neufeld; Dharma Thapa; Tomas Ganz; David A Weinstein; Melody J Cunningham
Journal:  Pediatr Blood Cancer       Date:  2007-01       Impact factor: 3.167

6.  Hepcidin in beta-thalassemia.

Authors:  Elizabeta Nemeth
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

7.  Liver iron concentrations and urinary hepcidin in beta-thalassemia.

Authors:  Raffaella Origa; Renzo Galanello; Tomas Ganz; Nicolina Giagu; Liliana Maccioni; Gavino Faa; Elizabeta Nemeth
Journal:  Haematologica       Date:  2007-05       Impact factor: 9.941

8.  Iron store and free radicals in thalassemia.

Authors:  K Goswami; S Ghosh; M Bandyopadhyay; K L Mukherjee
Journal:  Indian J Clin Biochem       Date:  2005-07

9.  Correlation of oxidative stress with serum trace element levels and antioxidant enzyme status in Beta thalassemia major patients: a review of the literature.

Authors:  Q Shazia; Z H Mohammad; Taibur Rahman; Hossain Uddin Shekhar
Journal:  Anemia       Date:  2012-05-09

Review 10.  Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders.

Authors:  Claudia R Morris; Mark T Gladwin; Gregory J Kato
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.